When COVID-19 Complicates Other Diagnoses

The medical community is rapidly trying to identify complications and patterns of disease to improve patient outcomes as the COVID-19 pandemic continues. Numerous studies have shown varying degrees of liver damage in... read more

When COVID-19 Complicates Other Diagnoses

Targeting Cellular Signalling Pathways in Lung Diseases

The book comprehensively reviews and provides detailed insight into the cellular and molecular signalling mechanisms involved in pathophysiology of various respiratory diseases, towards developing effective therapeutic strategies... read more

Targeting Cellular Signalling Pathways in Lung Diseases

COVID-19 Variant Classifications and Definitions

Genetic variants of SARS-CoV-2 have been emerging and circulating around the world throughout the COVID-19 pandemic. Viral mutations and variants in the United States are routinely monitored through sequence-based surveillance,... read more

COVID-19 Variant Classifications and Definitions

Inhaled Budesonide Improves Time to COVID-19 Recovery

Inhaled budesonide improves time to recovery, with a chance of also reducing hospital admissions or deaths (although our results did not meet the superiority threshold), in people with COVID-19 in the community who are at... read more

Inhaled Budesonide Improves Time to COVID-19 Recovery

Fungal Infections Complicating COVID-19

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections,... read more

Fungal Infections Complicating COVID-19

Time Course of Risk Factors Associated with COVID-19 Mortality

The present multicentric study describes 1,260 critically ill patients with COVID-19-associated acute respiratory failure consecutively admitted to 24 Italian ICUs during the first pandemic wave. This study specifically... read more

Time Course of Risk Factors Associated with COVID-19 Mortality

COVID-19 Variants in Patients with Immunosuppression

Patients with immunosuppression are at risk for prolonged infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In several case reports, investigators have indicated that multimutational SARS-CoV-2... read more

COVID-19 Variants in Patients with Immunosuppression

Full Vaccination Suppresses COVID-19 Delta Variant Mutation Frequency

This study presents the first evidence that full vaccination against COVID-19 suppresses emergent mutations of SARS-CoV-2 delta variants. An evolution algorithm, Tajima's D test with a threshold value as -2.50, can provide... read more

Full Vaccination Suppresses COVID-19 Delta Variant Mutation Frequency

NIH-convened Expert Panel Proposes Standardized Definition of Placental COVID-19 Infection

A panel of experts convened by the National Institutes of Health has recommended standardized criteria to define infection of the placenta with SARS-CoV-2, the virus that causes COVID-19. The panel also offers guidance... read more

NIH-convened Expert Panel Proposes Standardized Definition of Placental COVID-19 Infection

COVID-19, Online Shaming, and Health-care Professionals

Stigma and shame have been features of past pandemics. The stigma associated with disease can be experienced as shame by those who spread it. In almost all human cultures, there is shame attached to being “contaminated”,... read more

COVID-19, Online Shaming, and Health-care Professionals

Junior Doctors Write to Young People to Acknowledge Vaccine Concerns

A group of junior doctors from Scotland have written to young people in their age group to try to ease concerns they may have about receiving the covid-19 vaccine. In an open letter sent on Friday 6 August the doctors,... read more

Junior Doctors Write to Young People to Acknowledge Vaccine Concerns

RECOVERY-RS trial finds CPAP reduces need for invasive ventilation in hospitalised COVID-19 patients

The NIHR-supported Respiratory Strategies in COVID-19; CPAP, High-flow, and Standard Care (RECOVERY-RS) trial has demonstrated that treating hospitalised COVID-19 patients who have acute respiratory failure with continuous... read more

RECOVERY-RS trial finds CPAP reduces need for invasive ventilation in hospitalised COVID-19 patients

Adaptive Randomized Controlled Trial of Non-invasive Respiratory Strategies in ARF Patients with COVID-19

Continuous positive airway pressure (CPAP), compared with conventional oxygen therapy, reduced the composite outcome of intubation or death within 30 days of randomisation in hospitalized adults with acute respiratory failure... read more

Adaptive Randomized Controlled Trial of Non-invasive Respiratory Strategies in ARF Patients with COVID-19

Cystic Fibrosis in the COVID-19 Pandemic

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the development of life-threatening COVID-19 are believed to disproportionately affect certain at-risk populations. However, it is not clear whether... read more

Cystic Fibrosis in the COVID-19 Pandemic

Progressive Increase in Virulence of COVID-19 Variants

The progressive increase in transmissibility and virulence of SARS-CoV-2 VOCs will result in a significantly larger, and more deadly, pandemic than would have occurred in the absence of variants of concern (VOC) emergence. The... read more

Progressive Increase in Virulence of COVID-19 Variants

COVID-19: a boost for intensive care authorship?

Almost 180 million cases of COVID-19 have been diagnosed, with almost 4.000.000 deaths. Since this pandemic had unprecedented worldwide healthcare and socio-economic effects, the scientific world is under exceptional pressure... read more

COVID-19: a boost for intensive care authorship?

Managing Rising COVID-19 Cases in ICU

I have been working in intensive care for over 20 years, including a decade as a consultant, and facing winter pressures has always been the norm. However, the past 18 months have been something else. During the winter... read more

Managing Rising COVID-19 Cases in ICU

Incidence of Arrhythmia Higher in COVID-19 vs. Other CAPs

The incidence of arrhythmia was higher in COVID-19 than in other community-acquired pneumonia (CAP), with 2 out of 10 COVID-19 patients dying after developing arrhythmia. Higher incidence rates of conduction disorders... read more

Incidence of Arrhythmia Higher in COVID-19 vs. Other CAPs

COVID-19 Restructures the Host Chromatin Architecture

SARS-CoV-2 has made >190-million infections worldwide, thus it is pivotal to understand the viral impacts on host cells. Many viruses can significantly alter host chromatin, but such roles of SARS-CoV-2 are largely unknown.... read more

COVID-19 Restructures the Host Chromatin Architecture

Neuropsychiatric Disorders and COVID-19

We read with interest the Article by Maxime Taquet and colleagues1 in The Lancet Psychiatry that evaluated a large population (n=236 379) for neurological and psychiatric complications of COVID-19 via analysis of diagnostic... read more

Neuropsychiatric Disorders and COVID-19